Florencia Villafañez

Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction

Sofía Carbajosa, María Florencia Pansa, Natalia S. Paviolo et al. · Clinical Cancer Research · 2019 · 35 citations · Full text

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Florencia Villafañez, Iris Alejandra García, Sofía Carbajosa et al. · Oncogene · 2019 · 28 citations · Full text

Triggers Synthetic Lethality, Homologous Recombination-deficient Cells, Genome Instability +15

P53 tumor suppressor is required for efficient execution of the death program following treatment with a cytotoxic limonoid obtained from Melia azedarach

Mariana Belén Joray, Florencia Villafañez, María L. González et al. · Food and Chemical Toxicology · 2017 · 18 citations · Full text

Tumor Biology, Chemoprevention Strategy, Medicine +8

GSK-3 is an RNA polymerase II phospho-CTD kinase

Nicolás Nieto Moreno, Florencia Villafañez, Luciana E. Giono et al. · Nucleic Acids Research · 2020 · 13 citations · Full text